Panel Discussion: Analyzing the CMS Coverage with Evidence Development Model for Enhanced Access to Beneficiaries: A Real-World Evidence & Health Economics Perspective
Time: 2:15 pm
day: Conference Day One
Details:
- Assessing the scientific merit and clinical validity of interventions or therapies within Medicare/Medicaid-covered populations
- Exploring the reasonability and necessity of Medicare/Medicaid coverage for specific therapies
- Examining coverage contingent upon randomized control trials or real-world evidence studies to validate pre-market evidence in the applicable Medicare beneficiary population
- Aligning coverage with evidence development (CED) requirements and their relationship to outcomes expected in risksharing contracts
- Strategizing the integration of CED studies with existing risk-sharing contracts for optimal real-world evidence and health economics impact
